Terragen Holdings Limited
Terragen Holdings Limited (TGH.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Terragen Holdings Limited (TGH.AX), covering cash flow, earnings, and balance sheets.
Terragen Holdings Limited (TGH.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Terragen Holdings Limited TGH.AX financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $455799.00 | $455799.00 | $468174.00 | $468174.00 |
| Cost of Revenue | $222935.00 | $222935.00 | $15966.00 | $15966.00 |
| Gross Profit | $232864.00 | $232864.00 | $452208.00 | $452208.00 |
| Gross Profit Ratio | $0.51 | $0.51 | $0.97 | $0.97 |
| R&D Expenses | $590412.00 | $590412.00 | $896988.00 | $896988.00 |
| SG&A Expenses | $1.11M | $1.11M | $1.20M | $1.20M |
| Operating Expenses | $1.70M | $1.70M | $2.10M | $2.10M |
| Total Costs & Expenses | $1.92M | $1.92M | $2.11M | $2.11M |
| Interest Income | $0.00 | $0.00 | $69108.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $16472.00 | $0.00 |
| Depreciation & Amortization | $64976.00 | $25127.00 | $168887.00 | $36884.00 |
| EBITDA | -$1.44M | -$1.44M | -$1.79M | -$966706.00 |
| EBITDA Ratio | -$3.16 | -$3.16 | -$3.83 | -$2.06 |
| Operating Income | -$1.47M | -$1.47M | -$1.65M | -$1.65M |
| Operating Income Ratio | -$3.22 | -$3.22 | -$3.52 | -$3.52 |
| Other Income/Expenses (Net) | $29285.00 | $29285.00 | $656951.00 | $656951.00 |
| Income Before Tax | -$1.44M | -$1.44M | -$988725.00 | -$988725.00 |
| Income Before Tax Ratio | -$3.15 | -$3.15 | -$2.11 | -$2.11 |
| Income Tax Expense | -$575621.00 | $287811.00 | -$458704.00 | $229352.00 |
| Net Income | -$1.15M | -$1.15M | -$759373.00 | -$759373.00 |
| Net Income Ratio | -$2.52 | -$2.52 | -$1.62 | -$1.62 |
| EPS | -$0.003 | -$0.003 | -$0.002 | -$0.002 |
| Diluted EPS | -$0.003 | -$0.003 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $378.17M | $378.17M | $369.08M | $367.56M |
| Weighted Avg Shares Outstanding (Diluted) | $378.13M | $378.13M | $369.08M | $368.95M |
Over the past four quarters, Terragen Holdings Limited demonstrated steady revenue growth, increasing from $468174.00 in Q3 2024 to $455799.00 in Q2 2025. Operating income reached -$1.47M in Q2 2025, maintaining a consistent -322% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.44M, reflecting operational efficiency. Net income rose to -$1.15M, with EPS at -$0.003. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan